These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15768345)

  • 41. Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services.
    Whitley SD; Kunins HV; Arnsten JH; Gourevitch MN
    J Subst Abuse Treat; 2007 Jul; 33(1):85-90. PubMed ID: 17588493
    [TBL] [Abstract][Full Text] [Related]  

  • 42. On-site medical care in methadone maintenance: associations with health care use and expenditures.
    Gourevitch MN; Chatterji P; Deb N; Schoenbaum EE; Turner BJ
    J Subst Abuse Treat; 2007 Mar; 32(2):143-51. PubMed ID: 17306723
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment.
    Watson B; Conigrave KM; Wallace C; Whitfield JB; Wurst F; Haber PS
    Drug Alcohol Rev; 2007 May; 26(3):231-9. PubMed ID: 17454012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis C in injection drug users: It is time to treat.
    Grassi A; Ballardini G
    World J Gastroenterol; 2017 May; 23(20):3569-3571. PubMed ID: 28611509
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Harm reduction, hepatitis C and opioid pharmacotherapy: an opportunity for integrated hepatitis C virus-specific harm reduction.
    Hallinan R; Byrne A; Dore GJ
    Drug Alcohol Rev; 2007 Jul; 26(4):437-43. PubMed ID: 17564882
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Psychiatric barriers to readiness for treatment for hepatitis C Virus (HCV) infection among injection drug users: clinical experience of an addiction psychiatrist in the HIV-HCV coinfection clinic of a public health hospital.
    Scheft H; Fontenette DC
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S292-6. PubMed ID: 15768337
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004.
    Amon JJ; Garfein RS; Ahdieh-Grant L; Armstrong GL; Ouellet LJ; Latka MH; Vlahov D; Strathdee SA; Hudson SM; Kerndt P; Des Jarlais D; Williams IT
    Clin Infect Dis; 2008 Jun; 46(12):1852-8. PubMed ID: 18462109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Health-related quality of life in methadone maintenance patients with untreated hepatitis C virus infection.
    Batki SL; Canfield KM; Smyth E; Ploutz-Snyder R
    Drug Alcohol Depend; 2009 May; 101(3):176-82. PubMed ID: 19233573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. "It gives me a sense of belonging": providing integrated health care and treatment to people with HCV engaged in a psycho-educational support group.
    Woolhouse S; Cooper E; Pickard A
    Int J Drug Policy; 2013 Nov; 24(6):550-7. PubMed ID: 23860471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis.
    Judd A; Hutchinson S; Wadd S; Hickman M; Taylor A; Jones S; Parry JV; Cameron S; Rhodes T; Ahmed S; Bird S; Fox R; Renton A; Stimson GV; Goldberg D
    J Viral Hepat; 2005 Nov; 12(6):655-62. PubMed ID: 16255768
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Medical management of HIV-hepatitis C virus coinfection in injection drug users.
    Khalsa JH; Kresina T; Sherman K; Vocci F
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S1-6. PubMed ID: 16265605
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Linkage into specialist hepatitis C treatment services of injecting drug users attending a needle syringe program-based primary healthcare centre.
    Islam MM; Topp L; Conigrave KM; White A; Reid SE; Grummett S; Haber PS; Day CA
    J Subst Abuse Treat; 2012 Dec; 43(4):440-5. PubMed ID: 22938915
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improving access to sterile syringes and safe syringe disposal for injection drug users in methadone maintenance treatment.
    McNeely J; Arnsten JH; Gourevitch MN
    J Subst Abuse Treat; 2006 Jul; 31(1):51-7. PubMed ID: 16814010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Referral for chronic hepatitis C treatment from a drug dependency treatment setting.
    Hallinan R; Byrne A; Agho K; Dore GJ
    Drug Alcohol Depend; 2007 Apr; 88(1):49-53. PubMed ID: 17067763
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.
    Edlin BR; Kresina TF; Raymond DB; Carden MR; Gourevitch MN; Rich JD; Cheever LW; Cargill VA
    Clin Infect Dis; 2005 Apr; 40 Suppl 5(Suppl 5):S276-85. PubMed ID: 15768335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Challenges in the treatment of patients coinfected with HIV and hepatitis C virus: need for team care.
    Fleming CA; Tumilty S; Murray JE; Nunes D
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S349-54. PubMed ID: 15768347
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Individual and couple-level risk factors for hepatitis C infection among heterosexual drug users: a multilevel dyadic analysis.
    McMahon JM; Pouget ER; Tortu S
    J Infect Dis; 2007 Jun; 195(11):1572-81. PubMed ID: 17471426
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High prevalence of HBV and HCV infection among intravenous drug users in Korea.
    Yun H; Kim D; Kim S; Kang S; Jeong S; Cheon Y; Joe K; Gwon DH; Cho SN; Jee Y
    J Med Virol; 2008 Sep; 80(9):1570-5. PubMed ID: 18649342
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
    Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tuberculosis treatment through directly observed therapy in a large multisite methadone maintenance treatment program: addressing the public health needs of a high-risk population.
    Altarac D; Dansky SF
    J Public Health Manag Pract; 1995; 1(4):40-7. PubMed ID: 10186640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.